Home > Insider Trading > Filing (0001179110-20-010770)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
805928	Axogen Inc.	AXGN	Electromedical & Electrotherapeutic Apparatus (3845)	411301878

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1222357	J Peter Mariani	13631 Progress Boulevard Suite 400 Alachua FL 32615	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-10-30	60,000	$5.04	80,683	No	4	M	Direct
Common Stock	Disposition	2020-10-30	60,000	$12.41	20,683	No	4	S	Direct
Common Stock	Disposition	2020-10-30	1,084	$12.41	19,599	No	4	S	Direct
Common Stock	Disposition	2020-10-30	12,854	$12.41	6,745	No	4	S	Direct
Common Stock	Disposition	2020-10-30	1,745	$12.41	5,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Options (Right to Purchase)	Disposition	2020-10-30	60,000	$0.00	60,000	$5.04

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
145,000	2017-03-01	2023-03-01	No	4	M	Direct

Footnotes

Effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.06 to $12.96, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 2 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.05 to $12.96, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 3 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.14 to $12.96, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 4 to this Form 4.